![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 1. | J Garthwaite, E Southam, CL Boulton, EB Nielsen, K Schmidt, B Mayer | ||
|
|
Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | |
|---|---|---|---|
|
|
Mol. Pharmacol. Aug 01, 1995; 48: 184-188.
(In "ARTICLES") |
|
|
|
||
| 2. | S Grissmer, AN Nguyen, J Aiyar, DC Hanson, RJ Mather, GA Gutman, MJ Karmilowicz, DD Auperin, KG Chandy | ||
|
|
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines | |
|
|
Mol. Pharmacol. Jun 01, 1994; 45: 1227-1234.
(In "ARTICLES") |
|
|
|
||
| 3. | Toshimasa Ishizaki, Masayoshi Uehata, Ichiro Tamechika, Jeongsin Keel, Kimiko Nonomura, Midori Maekawa, Shuh Narumiya | ||
|
|
Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases | |
|
|
Mol. Pharmacol. May 01, 2000; 57: 976-983.
(In "ARTICLES") |
|
|
|
||
| 4. | K Williams | ||
|
|
Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors | |
|
|
Mol. Pharmacol. Oct 01, 1993; 44: 851-859.
(In "ARTICLES") |
|
|
|
||
| 5. | S Pippig, S Andexinger, MJ Lohse | ||
|
|
Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization | |
|
|
Mol. Pharmacol. Apr 01, 1995; 47: 666-676.
(In "ARTICLES") |
|
|
|
||
| 6. | CM Flores, SW Rogers, LA Pabreza, BB Wolfe, KJ Kellar | ||
|
|
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment | |
|
|
Mol. Pharmacol. Jan 01, 1992; 41: 31-37.
(In "ARTICLES") |
|
|
|
||
| 7. | Bryan Goodwin, Ecushla Hodgson, Christopher Liddle | ||
|
|
The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module | |
|
|
Mol. Pharmacol. Dec 01, 1999; 56: 1329-1339.
(In "ARTICLES") |
|
|
|
||
| 8. | Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping, Caroline S. Hill | ||
|
|
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor- Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7 |
|
|
|
Mol. Pharmacol. Jul 01, 2002; 62: 65-74.
(In "ARTICLES") |
|
|
|
||
| 9. | Tomas Barkhem, Bo Carlsson, Yvonne Nilsson, Eva Enmark, Jan-Åke Gustafsson, Stefan Nilsson | ||
|
|
Differential Response of Estrogen Receptor  and Estrogen Receptor to Partial Estrogen Agonists/Antagonists |
|
|
|
Mol. Pharmacol. Jul 01, 1998; 54: 105-112.
(In "ARTICLES") |
|
|
|
||
| 10. | Luc Ménard, Stephen S. G. Ferguson, Jie Zhang, Fang-Tsyr Lin, Robert J. Lefkowitz, Marc G. Caron, Larry S. Barak | ||
|
|
Synergistic Regulation of 2-Adrenergic Receptor Sequestration: Intracellular Complement of -Adrenergic Receptor
Kinase and -Arrestin Determine Kinetics of Internalization |
|
|
|
Mol. Pharmacol. May 01, 1997; 51: 800-808.
(In "ARTICLES") |
|
|
|
||
| [Next 10 Articles] | |||
= from the current issue
Last Updated: 08/09/2008 10:42:18
 |
 |
 |
|
 |
 |
 |